| 中文名称 | 利福霉素S |
|---|---|
| 中文别名 | 利福霉素-S;利福霉素 S;利福毒素S;利福霉素;利福霉素S EP标准品;福霉素-S;利福平霉素;1,4-二脱氧-1,4-二氢-1,4-二氧代利福霉素;利福霉素S;利福霉素-D4 |
| 英文名称 | Rifamycin S |
| 英文别名 | Rifamycin S;1,4-Dideoxy-1,4-dihydro-1,4-dioxo-rifamycin;Rifampicin S;rifomycin S;(12S,3E,5S,13E,15Z)-7t-acetoxy-15,9c,11t-trihydroxy-5r-methoxy-12,4,6t,8c,10c,12t,16-heptamethyl-2-oxa-18-aza-1(2,7)-naphtho[2,1-b]furana-cyclooctadecaphane-3,13,15-triene-11,6,9,17-tetraone;1,4-Dideoxy-1,4-dihydro-1,4-dioxorifamycin;EINECS 236-938-4;NCI 144-130;O1,O4-didehydro-rifamycin;Rifamycin,1,4-dideoxy-1,4-dihydro-1,4-dioxo;rifamycin-S;rifaximin S;rifomycin-S;UNII-PI53N820JV;Rifaximin EP Impurity E;Rifaximin impurity E (EP);4-dideoxy-1,4-dihydro-1,4-dioxo-rifamycin;Rifamycin, 1,4-dideoxy-1,4-dihydro-1,4-dioxo-;5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-21-aceta;rifomycins;nci144-130;s4425;MFCD06198807;PI53N820JV;13553-79-2;DTXSID301043935;NSC 144130;RIFAMYCIN S [EP IMPURITY];RIFAXIMIN IMPURITY E [EP IMPURITY];RIFAMYCIN SODIUM IMPURITY B [EP IMPURITY];((2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,17,19-TRIHYDROXY-23-METHOXY-2,4,12,16,18,20,22-HEPTAMETHYL-1,6,9,11-TETRAOXO-1,2-DIHYDRO-2,7-(EPOXYPENTADECA(1,11,13)TRIENAZANO)NAPHTHO(2,1-B)FURAN-21-YL ACETATE;Rafamycin S;NSC144130;SCHEMBL415695;Q27116328;[(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl] acetate;2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,6,9,11(2H)-tetrone, 5,17,19,21-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate;BTVYFIMKUHNOBZ-ODRIEIDWSA-N;CHEMBL236921;BRN 0604802;CHEBI:34948;RIFAMYCIN S [MI];NSC-144130;RIFAMYCIN S (EP IMPURITY);RIFAMYCIN SODIUM IMPURITY B (EP IMPURITY);RIFAXIMIN IMPURITY E (EP IMPURITY);A11758;((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17-trihydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(28),2,4,9,19,21,25-heptaen-13-yl) acetate |
| CAS No. | 13553-79-2 |
| 分子式 | C37H45NO12 |
| 分子量 | 695.75 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学